The AVENIO Tumor Tissue Targeted Kit is a 17 gene (81kb) pan-cancer assay that contains guideline-aligned biomarkers, including those identified by the U.S. National Comprehensive Cancer Network (NCCN).
Learn moreThe AVENIO Tumor Tissue Expanded Kit is a 77 gene (192kb) pan-cancer assay that contains 17 NCCN guideline-aligned genes, plus 60 emerging biomarkers investigated in clinical research for expanded profiling of solid tumors.
Learn moreThe AVENIO Tumor Tissue Surveillance Kit is a 197 gene (198kb) pan-cancer assay that contains 17 NCCN guideline-aligned genes, plus 471 frequently mutated disease-associated regions across 180 genes; optimized for longitudinal monitoring of tumor burden and detection of minimal residual disease in lung cancer and colorectal cancer.
Learn more